CFDE Data Portal | Search CACNA1G-AS1

	Label	Description
	CACNA1G-AS1 associations Collection (Entity type)	Associations for CACNA1G-AS1_associations
	CACNA1G-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CACNA1G-AS1 Gene (Entity type)	ENSG00000250107 - CACNA1G antisense RNA 1
	GSE114883 romidepsin T cell 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 3 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 5 V 10 PREDNISOLONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 3 V 5 PACLITAXEL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE57871 5 V 9 VORINOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE236896 GSE237665 DNMT EZH2 inhibition 1 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE109913 1 V 2 BLEOMYCIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

CACNA1G-AS1 associations

Associations for CACNA1G-AS1_associations

CACNA1G-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

CACNA1G-AS1

ENSG00000250107 - CACNA1G antisense RNA 1

GSE114883 romidepsin T cell 1 v 2 human up

A Gene Set from LINCS

GSE187006 3 V 2 VALPROIC ACID HUMAN UP

A Gene Set from LINCS

GSE164874 5 V 10 PREDNISOLONE HUMAN DN

A Gene Set from LINCS

GSE228106 3 V 5 PACLITAXEL HUMAN DN

A Gene Set from LINCS

GSE57871 5 V 9 VORINOSTAT HUMAN UP

A Gene Set from LINCS

GSE236896 GSE237665 DNMT EZH2 inhibition 1 v 5 human dn

A Gene Set from LINCS

GSE109913 1 V 2 BLEOMYCIN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.